East and West: Managing New Hep C Drug Side Effects
Combining two different medical traditions may provide the best relief for side effects originating from the latest Hepatitis C drugs.
Continue reading »Combining two different medical traditions may provide the best relief for side effects originating from the latest Hepatitis C drugs.
Continue reading »The Bristol-Myers Squibb Foundation has recently awarded three grants in an effort to prevent, diagnose and care for those with Hepatitis B and Hepatitis C in China and India.
Continue reading »Because three quarters of Hepatitis C patients relapsed after stopping Gilead's GS-7977, the company's financial profile suffered.
Continue reading »Since an estimated one third of HIV patients are also infected with Hepatitis C, knowing about the potential interaction between boceprevir and certain HIV medications is imperative.
Continue reading »We usually think of Hepatitis C as a virus that is passed from person to person. However, most infections occur via an intermediary, inanimate object. Thus, determining the length of time Hepatitis C can survive outside the body is crucial to prevent transmission of this virus.
Continue reading »Maryland researchers have published a study detailing the usefulness of the ALT liver enzyme test to differentiate between those at high and low risk of having liver disease.
Continue reading »New research shows that even if Hepatitis B is hidden, it can still cause serious harm.
Continue reading »A prominent UCLA researcher pinpoints the protein that blocks Hepatitis C viral replication and could ultimately end the problem of medication resistance during Hepatitis C therapy.
Continue reading »Spearheaded by a research team spanning several respected U.S. universities, stem cells are showing promise in understanding some of the challenges presented by the Hepatitis C virus.
Continue reading »It's hard to imagine that intravenous drug use and mani-pedis have much in common, but they both harbor the potential to spread viral hepatitis.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window